Literature DB >> 17460114

Exocytosis of Neutrophil Formyl peptide receptor-like 1 (fPRL1) results in downregulation of cytoplasmic fPRL1 in patients with purulent dermatitis.

Eiji Ohara1, Yoshitaka Kumon, Toshihiro Kobayashi, Hiroaki Takeuchi, Tetsuro Sugiura.   

Abstract

N-Formyl peptide receptor-like 1 (fPRL1) is a member of the chemoattractant subfamily of G protein-coupled receptors and plays a key role in inflammation via chemotaxis and the regulation of mediator release from leukocytes. Activated fPRL1 has recently been shown to induce a complicated pattern of cellular signaling in vitro, but the details of the regulation and alteration of leukocyte cellular fPRL1 during inflammation in vivo remain unclear. To clarify the alteration of neutrophil fPRL1 during inflammation in vivo, the immunohistochemical staining of neutrophil fPRL1 in samples from patients with purulent dermatitis was performed. The in vitro morphological alteration of neutrophil fPRL1 on cellular membranes by stimulation with N-formylmethionyl-leucyl-phenylalanine (fMLP) was also examined. Both the cytoplasm and the cellular membranes of blood neutrophils stained strongly for fPRL1. On the other hand, the cellular membranes of neutrophils in dermatitis tissue stained strongly for fPRL1 but the cytoplasm stained weakly. The enhancement of neutrophil fPRL1 on cellular membranes by stimulation with fMLP indicates the exocytosis of neutrophil fPRL1-containing granules. In conclusion, we for the first time confirmed the alteration of neutrophil fPRL1 in clinical cases of purulent dermatitis. Cytoplasm that was weakly stained and cellular membranes that were well stained for fPRL1 were considered to be distinctive features of activated neutrophils in purulent dermatitis tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460114      PMCID: PMC1951091          DOI: 10.1128/CVI.00426-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  26 in total

Review 1.  Apoptosis and the regulation of neutrophil lifespan.

Authors:  M Whyte; S Renshaw; R Lawson; C Bingle
Journal:  Biochem Soc Trans       Date:  1999-12       Impact factor: 5.407

Review 2.  Formyl-peptide receptors revisited.

Authors:  Yingying Le; Philip M Murphy; Ji Ming Wang
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

Review 3.  Neutrophil granules and secretory vesicles in inflammation.

Authors:  Mikkel Faurschou; Niels Borregaard
Journal:  Microbes Infect       Date:  2003-11       Impact factor: 2.700

4.  Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe.

Authors:  J Almkvist; J Fäldt; C Dahlgren; H Leffler; A Karlsson
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Transcriptional regulation of serum amyloid A1 gene expression in human aortic smooth muscle cells involves CCAAT/enhancer binding proteins (C/EBP) and is distinct from HepG2 cells.

Authors:  Y Kumon; T Suehiro; D J Faulkes; T Hosakawa; Y Ikeda; P Woo; J D Sipe; K Hashimoto
Journal:  Scand J Immunol       Date:  2002-11       Impact factor: 3.487

6.  Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1.

Authors:  Johan Bylund; Anna Karlsson; Francois Boulay; Claes Dahlgren
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

7.  NADPH-oxidase activation in murine neutrophils via formyl peptide receptors.

Authors:  Johan Bylund; Marie Samuelsson; L Vincent Collins; Anna Karlsson
Journal:  Exp Cell Res       Date:  2003-01-15       Impact factor: 3.905

8.  Acute-phase, but not constitutive serum amyloid A (SAA) is chemotactic for cultured human aortic smooth muscle cells.

Authors:  Yoshitaka Kumon; Takanori Hosokawa; Tadashi Suehiro; Yukio Ikeda; Jean D Sipe; Kozo Hashimoto
Journal:  Amyloid       Date:  2002-12       Impact factor: 7.141

9.  Enzyme-linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptide.

Authors:  A Barkia; C Martin; P Puchois; J C Gesquiere; C Cachera; A Tartar; J C Fruchart
Journal:  J Lipid Res       Date:  1988-01       Impact factor: 5.922

10.  A novel intracellular compartment with unusual secretory properties in human neutrophils.

Authors:  T Kobayashi; J M Robinson
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.